Literature DB >> 15627436

Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models.

Raymond F Orzechowski1, Debra S Currie, Cathryn A Valancius.   

Abstract

We determined the relative rank orders of anticholinergic potencies of 10 antihistamines in two functional bioassays: (1) an in vitro assay measuring inhibition of carbachol-induced contractions of isolated guinea pig trachealis muscle, (2) an in vivo bioassay comparing systemic hypotensive responses to bolus i.v. injections of acetylcholine before and after infusions of an antihistamine in anaesthetized rats. In vitro, the rank order of anticholinergic potencies of the antihistamines was cyproheptadine>promethazine>desloratadine>diphenhydramine>loratadine>chlorpheniramine>hydroxyzine>pyrilamine. The pA2 values ranged from 8.2+/-0.4 for cyproheptadine to 4.8+/-0.4 for pyrilamine. Fexofenadine and cetirizine (up to 3 x 10(-4) M) were inactive. In vivo, five antihistamines showed anticholinergic activity: cyproheptadine>promethazine>desloratadine>loratadine>diphenhydramine. The remaining antihistamines had no significant effect at i.v. infusion doses up to 50 imol/kg. Cetirizine and fexofenadine did not antagonize cholinergic responses in either model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627436     DOI: 10.1016/j.ejphar.2004.11.006

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use.

Authors:  Mehmet Sofuoglu
Journal:  Addiction       Date:  2012-02       Impact factor: 6.526

2.  Cyproheptadine Regulates Pyramidal Neuron Excitability in Mouse Medial Prefrontal Cortex.

Authors:  Yan-Lin He; Kai Wang; Qian-Ru Zhao; Yan-Ai Mei
Journal:  Neurosci Bull       Date:  2018-04-18       Impact factor: 5.203

3.  Induction of prolonged, continuous slow-wave sleep by blocking cerebral H₁ histamine receptors in rats.

Authors:  Masami Ikeda-Sagara; Tomoya Ozaki; Mohammad Shahid; Eri Morioka; Kazuma Wada; Kazuki Honda; Ayana Hori; Yuji Matsuya; Naoki Toyooka; Masayuki Ikeda
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 4.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 5.  Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.

Authors:  William P Cheshire; Robert D Fealey
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology.

Authors:  Michael J Kimber; Laura Sayegh; Fouad El-Shehabi; Chuanzhe Song; Mostafa Zamanian; Debra J Woods; Tim A Day; Paula Ribeiro
Journal:  Int J Parasitol       Date:  2009-03-25       Impact factor: 3.981

Review 7.  Older-generation antihistamines and cough due to upper airway cough syndrome (UACS): efficacy and mechanism.

Authors:  Donald C Bolser
Journal:  Lung       Date:  2007-10-02       Impact factor: 2.584

Review 8.  Cocaine adulteration.

Authors:  Oliver Kudlacek; Tina Hofmaier; Anton Luf; Felix P Mayer; Thomas Stockner; Constanze Nagy; Marion Holy; Michael Freissmuth; Rainer Schmid; Harald H Sitte
Journal:  J Chem Neuroanat       Date:  2017-06-12       Impact factor: 3.097

9.  Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand.

Authors:  Gabriel Dapaah; George Asumeng Koffuor; Priscilla Kolibea Mante; Inemesit Okon Ben
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

10.  Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells.

Authors:  Josep M Cornet-Masana; Antònia Banús-Mulet; José M Carbó; Miguel Ángel Torrente; Francesca Guijarro; Laia Cuesta-Casanovas; Jordi Esteve; Ruth M Risueño
Journal:  EBioMedicine       Date:  2019-08-28       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.